Challenges in the design and conduct of controlled clinical effectiveness trials in schizophrenia
Challenges in the design and conduct of controlled clinical effectiveness trials in schizophrenia
About this item
Full title
Author / Creator
Publisher
London, England: SAGE Publications
Journal title
Language
English
Formats
Publication information
Publisher
London, England: SAGE Publications
Subjects
More information
Scope and Contents
Contents
Background
The introduction of antipsychotic medication has been a major advance in the treatment of schizophrenia and allows millions of people to live outside of institutions. It is generally believed that long-acting intramuscular antipsychotic medication is the most effective approach to increasing medication adherence and thereby reduce rel...
Alternative Titles
Full title
Challenges in the design and conduct of controlled clinical effectiveness trials in schizophrenia
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_883017890
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_883017890
Other Identifiers
ISSN
1740-7745,1740-7753
E-ISSN
1740-7753
DOI
10.1177/1740774510392931
